SETD1B and hepatocellular carcinoma: As a member of the human SET1 family, SETD1B is capable of catalyzing the methylation of histone H3 at lysine 4 (H3K4) 35, and abnormally elevated levels of SETD1B expression correlate with poor prognostic outcomes in HCC 36.